Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
International Journal of Psychiatry in Clinical Practice|June 17, 2014
Fluvoxamine for the treatment of depression and parkinsonism in progressive supranuclear palsyTsuyoshi Miyaoka, Haruo Seno, Takuji Inagaki, et al.Psychiatry and Clinical Neurosciences|December 17, 2004
Effects of donepezil on Alzheimer's disease: the relationship between cognitive function and rapid eye movement sleepSoichi Mizuno, Atsuko Kameda, Takuji Inagaki, et al.Current Pharmaceutical Design|May 16, 2009
New approaches to antidepressant drug design: cytokine-regulated pathwaysAkira Nishida, Tsuyoshi Miyaoka, Takuji Inagaki, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 5, 2008
Effect of Yi-Gan San on psychiatric symptoms and sleep structure at patients with behavioral and psychological symptoms of dementiaHideto Shinno, Yasushi Inami, Takuji Inagaki, et al.Case Reports in Psychiatry|October 12, 2012
May salivary alpha-amylase level be a useful tool for assessment of the severity of schizophrenia and evaluation of therapy? A case reportMasa Ieda, Tsuyoshi Miyaoka, Kiminori Kawano, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 13, 2006
Possible antipsychotic effects of minocycline in patients with schizophreniaTsuyoshi Miyaoka, Rei Yasukawa, Hideaki Yasuda, et al.Clinical Neuropharmacology|October 7, 2008
Minocycline as adjunctive therapy for schizophrenia: an open-label studyTsuyoshi Miyaoka, Rei Yasukawa, Hideaki Yasuda, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 4, 2007
Yi-gan san for the treatment of borderline personality disorder: an open-label studyTsuyshi Miyaoka, Motohide Furuya, Hideaki Yasuda, et al.International Journal of Psychiatry in Clinical Practice|June 18, 2014
Late-onset schizophrenia with epileptiform dischargeT Miyaoka Haruo Seno Chikako Yamamori Masaaki Iijima Takuji Inagaki Jun HoriguchiPsychiatry Research|August 28, 2007
Increased urinary excretion of biopyrrins, oxidative metabolites of bilirubin, in patients with schizophreniaRei Yasukawa, Tsuyoshi Miyaoka, Hideaki Yasuda, et al.Pageof 4